Page 39 - Simulations Plus Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

IMARC Group expects the market to grow at a CAGR of around 21% during 2021-2026.

Simulations Plus Inc. received an order from China’s drug evaluation agency to license its GastroPlus product. Financial terms of the deal between the Lancaster drug modeling software developer and the Center for Drug Evaluation of the National Medical Products Administration in China were not disclosed. John DiBella, Simulations Plus division president said, the company has cultivated relationships with different institutions affiliated with China’s National Medical Products Administration to use its technology for the evaluation of drug specifications and bioequivalence. “Now, researc...

Share this article Share this article NEW YORK, July 26, 2021 /PRNewswire/ -- The biosimulation market is poised to grow by USD 2.09 billion during 2021-2025, progressing at a CAGR of 13.17% during the forecast period. Here is an Exclusive report talking about Market scenarios, Estimates, the impact of lockdown, and Customer Behaviour. Attractive Opportunities in Biosimulation Market - Forecast 2021-2025 The report on the biosimulation market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis. The report offers an up-to-...

Simulations Plus Reports Third Quarter Fiscal 2021 Financial Results Third quarter total revenue increased 4% to $12.8 million, with software revenue up 21%; Board of Directors announces quarterly dividend of $0.06 per share LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemical, and consumer goods industries, today reported financial results for its third quarter of fiscal 2021, ended May 31, 2021. Third Quarter Fiscal 2021 Financial highlights (c...

Simulations Plus, inc (SLP) Q3 2021 Earnings Call Transcript Motley Fool Transcribers © The Motley Fool Logo of jester cap with thought bubble. Simulations Plus, inc (NASDAQ: SLP) Q3 2021 Earnings Call Operator Greetings and welcome to the Simulations Plus Third Quarter Fiscal 2021 Financial Results Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce Brian Siegel from Hayden IR. Thank you Mr. Siegel. You may begin.SPONSORED: 10 stocks we like better than Simulations Plus, Inc. When our award-winni...